An interventional study of 3 RP in Post Traumatic Stress Disorder (PTSD), sponsored by NYU Langone Health. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-10-18.
Sponsored by NYU Langone Health · Not applicable, Interventional, and Supportive care
The objective of this protocol is to test the feasibility and acceptability of the Relaxation Response Resiliency Program (3RP), a psychotherapy treatment providing a variety of mind body skills and interventions to decrease medical and mental health symptoms and build resilience, in Spanish-speaking World Trade Center (WTC) survivors, and to examine its clinical effectiveness to reduce Post Traumatic Stress Disorder (PTSD), depression, anxiety, and lower respiratory symptoms (LRS) and improve psychosocial functioning.
1,147 studies on the registry are indexed under Stress Disorders, Traumatic; 108 are open to participants now.
This study's enrollment of 20 is below the median of 60 across 908 interventional studies indexed under Stress Disorders, Traumatic.
Browse Stress Disorders, Traumatic studies →NYU Langone Health is the lead sponsor of 1,391 studies on the registry; 254 are open to participants now.
Of its 227 completed or terminated interventional studies of FDA-regulated products, 191 (84%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Behavioral: 3 RP
Also known as: Relaxation Response Resiliency Program
Structured Clinical Interview (SCID-NP) for Diagnostic and Statistical Manual DSM-IV
State-of-the-art instrument for obtaining psychiatric diagnoses.
Time frame: 1 Month
Symptom Severity using PTSD Checklist
Symptoms will be assessed with the PTSD Checklist (PCL), a 17-item self-report measure of current (past month) PTSD symptoms based on the DSM-IV criteria. It is a widely-used and validated measure of PTSD symptom severity.
Time frame: 1 Month
Assessment of Anxiety Symptoms using Generalized Anxiety Disorder Scale (GAD-7)
Time frame: 1 Month
Measure of Functional Impairment using the Range of Impaired Functioning Tool (RIFT)
widely-used instrument that taps the domains of work, household duties, interpersonal relationships, recreation, and subjective satisfaction with life. Each domain is rated on a five-point scale from very good to very poor. The total score is the sum of the different domains.
Time frame: 1 Month
Assessment of Mindful attention using Mindful Attention Awareness Scale (MAAS)
The MAAS is a 15-item questionnaire on which respondents indicate, on a 6 point Likert-type scale (1 = almost always to 6 = almost never), their level of awareness and attention to present events and experiences.
Time frame: 1 Month
Health Promoting Behaviors will be assessed with the Health Promoting Lifestyles Profile-II (HPLP-II)
he HPLP-II is a 52 item self-report inventory of health behaviors and has been used in previous mind-body treatment studies
Time frame: 1 Month
Measure of treatment expectancy using the Treatment Credibility/Expectancy Questionnaire.
The 6-item Treatment Credibility/Expectancy Questionnaire (CEQ)84 will be used to examine treatment expectancy related to the 3RP.
Time frame: 1 Month
This study is completed, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
NYU Langone Health